Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02027961 |
Title | Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib Alone |
Recruitment | Completed |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | Yes |
Sponsors | MedImmune LLC |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | ITA | FRA | CAN |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Research Site | Scottsdale | Arizona | 85258 | United States | Details | |
Research Site | Los Angeles | California | 90095 | United States | Details | |
Research Site | San Francisco | California | 94115 | United States | Details | |
Research Site | Miami Beach | Florida | 33140 | United States | Details | |
Research Site | Chicago | Illinois | 60611 | United States | Details | |
Research Site | Boston | Massachusetts | 02114 | United States | Details | |
Research Site | Saint Louis | Missouri | 63110 | United States | Details | |
Research Site | Toronto | Ontario | M5G 2M9 | Canada | Details | |
Research Site | Montreal | Quebec | H3A 1A1 | Canada | Details | |
Research Site | Villejuif | 94805 | France | Details | ||
Research Site | Napoli | 80131 | Italy | Details |